Hereditary Angioedema (HAE) Archives - Page 5 of 7 - Biocryst

Global Perceptions of the Current and Future Impacts of COVID-19 on Hereditary Angioedema Management

View Article

biocryst

February 12, 2025

Hereditary Angioedema (HAE)
Berotralstat (BCX7353) is a Novel, Oral Prophylactic Treatment for Hereditary Angioedema: Review of Phase II and III Studies

View Article

biocryst

February 12, 2025

Hereditary Angioedema (HAE)
Androgen Use in Hereditary Angioedema: A Critical Appraisal and Approaches to Transitioning from Androgens to Other Therapies

View Article

biocryst

February 12, 2025

Hereditary Angioedema (HAE)
Oral Berotralstat for the Prophylaxis of Hereditary Angioedema Attacks in Patients in Japan: A Phase 3 Randomized Trial

View Article

biocryst

February 12, 2025

Hereditary Angioedema (HAE)
Expert Consensus on Prophylactic Treatment of Hereditary Angioedema

View Article

biocryst

February 12, 2025

Hereditary Angioedema (HAE)
Significant response to berotralstat in 3 patients with hereditary angioedema of unknown origin

View Article

biocryst

January 27, 2025

Hereditary Angioedema (HAE)
A Retrospective Analysis of Long-Term Prophylaxis with Berotralstat in Patients with Hereditary Angioedema and Acquired C1-Inhibitor Deficiency-Real-World Data

View Article

biocryst

January 27, 2025

Hereditary Angioedema (HAE)
Berotralstat for hereditary angioedema with C1 inhibitor deficiency: a practical guide for clinicians

View Article

biocryst

January 27, 2025

Hereditary Angioedema (HAE)
Patient-reported burden of hereditary angioedema: findings from a patient survey in the United States

View Article

biocryst

January 27, 2025

Hereditary Angioedema (HAE)
Clinical features of genetically characterized types of hereditary angioedema with normal C1 inhibitor: a systematic review of qualitative evidence

View Article

biocryst

January 27, 2025

Hereditary Angioedema (HAE)